{"id":"75f5c7fd-a3f8-4c7b-804b-9c0e19d1aad9","kind":"news","code":"75f5c7fd-a3f8-4c7b-804b-9c0e19d1aad9","name":"Iambic Therapeutics raises USD 50 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Iambic Therapeutics完成5000万美元B轮融资","eventDate":"2024-06-24T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:21.945Z","englishUpdatedAt":"2026-10-15T17:19:59.648Z","reviewedAt":"2026-10-15T17:19:59.648Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb75c603c0171197a17001749697d414830f361c52dda8ca0eb35d5f9c82c31e","companyId":"217c9186-2e9b-4e07-b192-25de64a27b49","foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"a97ab4fe-1746-4dba-8c40-87edb3b96400","kind":"institutions","code":"UB-I1548","name":"Abingworth","nameBasis":"original-brand","summary":"A long-established UK specialist life sciences investment firm covering early-stage biotech and public markets.","description":"A long-established UK specialist life sciences investment firm covering early-stage biotech and public markets.","country":null,"category":null,"originalName":"Abingworth","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:25.538Z","englishUpdatedAt":"2026-10-15T21:31:30.002Z","reviewedAt":"2026-10-15T21:31:30.002Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0418db3ef8d6cd34e6baf8c0e882a6caf60640456d3db78d20d77a8cf255ee50","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/abingworth"},{"id":"228c4e4b-9fd3-4730-8441-497ab5d22b99","kind":"institutions","code":"UB-I060","name":"Coatue","nameBasis":"original-brand","summary":"A global technology growth investment and hedge fund focused on growth-stage investments in technology, consumer businesses, and healthcare.","description":"A global technology growth investment and hedge fund focused on growth-stage investments in technology, consumer businesses, and healthcare.","country":"United States","category":null,"originalName":"Coatue","eventDate":null,"website":"https://coatue.com/","sourceUpdatedAt":"2026-10-20T07:00:15.389Z","englishUpdatedAt":"2026-10-20T18:26:49.540Z","reviewedAt":"2026-10-20T18:26:49.540Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"20d32163d26e6aaf4bad5feb4f53973416976e1c5ea6036b24541f3419afde51","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/coatue"},{"id":"951b922f-4325-4c42-8662-e35416dfab9b","kind":"institutions","code":"UB-I5862","name":"Exor Ventures","nameBasis":"original-brand","summary":"Exor Ventures, under the Agrello/Exor group.","description":"Exor Ventures, under the Agrello/Exor group.","country":null,"category":null,"originalName":"Exor Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:10:25.219Z","englishUpdatedAt":"2026-10-15T21:28:29.644Z","reviewedAt":"2026-10-15T21:28:29.644Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d06df1c81473813449dd238e38e717fc7ce7b5d024150296bc4b845d9e03193b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/exor-ventures"},{"id":"217c9186-2e9b-4e07-b192-25de64a27b49","kind":"companies","code":"UB-C1874","name":"Iambic Therapeutics","nameBasis":"source-english","summary":"","description":"","country":"United States","category":null,"originalName":"Iambic Therapeutics","eventDate":null,"website":"https://www.iambic.ai/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:22:58.396Z","reviewedAt":"2026-10-20T18:22:58.396Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"210444ecf820598a6766ca0feeb655698cebdca5894e1146f09f5f1c2014911d","companyId":null,"foundedYear":2019,"logoUrl":null,"path":"/companies/iambic-therapeutics"},{"id":"e3b56de9-fe2e-48d1-a458-4d066c8c6b05","kind":"institutions","code":"UB-I1521","name":"Illumina Ventures","nameBasis":"original-brand","summary":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","description":"The venture capital division of gene sequencing leader Illumina, focused on genomics and precision medicine.","country":"United States","category":null,"originalName":"Illumina Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:16.444Z","englishUpdatedAt":"2026-10-20T18:27:03.932Z","reviewedAt":"2026-10-20T18:27:03.932Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"42c6811f542a7c7bd5b90e2c7d9d4713fdd7a03bf5996281a1c14cdf5904fa25","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/illumina-ventures"},{"id":"bfb10b6e-bb33-4250-96da-17b077d6690e","kind":"institutions","code":"UB-I415","name":"Mubadala Capital","nameBasis":"original-brand","summary":"The investment management division of Abu Dhabi sovereign wealth fund Mubadala.","description":"The investment management division of Abu Dhabi sovereign wealth fund Mubadala.","country":null,"category":null,"originalName":"Mubadala Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:26.021Z","englishUpdatedAt":"2026-10-15T21:02:48.877Z","reviewedAt":"2026-10-15T21:02:48.877Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ce226d980093842a6a1e7e5365acbd4625bfd44de0bae98bef6a0d02d375e9cb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/mubadala-capital"},{"id":"e5c94897-887d-4b83-8fcb-c48c47ffb8ec","kind":"institutions","code":"UB-I600","name":"Nexus Venture Partners","nameBasis":"original-brand","summary":"An early- and growth-stage venture capital firm in India.","description":"An early- and growth-stage venture capital firm in India.","country":"United States","category":null,"originalName":"Nexus Venture Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T23:00:12.436Z","englishUpdatedAt":"2026-10-20T18:27:13.895Z","reviewedAt":"2026-10-20T18:27:13.895Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"b852cbdaa3948e5dab31f2cfa6b56946e76a52bd81826b3e7498f7a9353595e0","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nexus-venture-partners"},{"id":"f0627977-1d13-4af9-b515-929246c702bf","kind":"institutions","code":"UB-I104","name":"Qatar Investment Authority","nameBasis":"original-brand","summary":"A Qatari sovereign wealth fund and global long-term institutional investor allocating across a wide range of assets.","description":"A Qatari sovereign wealth fund and global long-term institutional investor allocating across a wide range of assets.","country":null,"category":null,"originalName":"Qatar Investment Authority","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.711Z","englishUpdatedAt":"2026-10-15T21:21:01.805Z","reviewedAt":"2026-10-15T21:21:01.805Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"544fef210964b844483f771bd3590e92f7e6123ea837288b50803dba207ab452","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/qatar-investment-authority"},{"id":"e1253608-ff22-4fcf-b23c-fb25c619a035","kind":"institutions","code":"UB-I812","name":"Tao Capital Partners","nameBasis":"original-brand","summary":"Tao Capital Partners, an investment firm.","description":"Tao Capital Partners, an investment firm.","country":"United States","category":null,"originalName":"Tao Capital Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T22:00:21.202Z","englishUpdatedAt":"2026-10-20T18:27:03.901Z","reviewedAt":"2026-10-20T18:27:03.901Z","snapshotAt":"2026-10-20T18:10:00.657Z","sourceHash":"3c97078f078e6362c9c41d0cc53232e76268a78ea7e99f460a0310b84272cc03","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/tao-capital-partners"}],"path":"/news/75f5c7fd-a3f8-4c7b-804b-9c0e19d1aad9","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Iambic Therapeutics","path":"/companies/iambic-therapeutics"}},"canonical":"https://uniquebase.ai/news/75f5c7fd-a3f8-4c7b-804b-9c0e19d1aad9"}